Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marrow Concentrate for CCJ Instability
NCT03517761Recruiting
- Sponsor
- Regenexx
- Start
- Mar 2018
- Primary completion
- Dec 2030
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous bone marrow cell concentrate in Cranio-cervical instability (CCI), sponsored by Regenexx. Primary endpoint: Headache Impact Test. Started Mar 2018; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
Cranio-cervical instability (CCI)
Beyond the preview
Go deeper on NCT03517761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03517761.